Thrombotic microangiopathy associated with use of interferon-beta

Interferon-beta is widely used for the treatment of relapsing multiple sclerosis. The drug is usually well tolerated, but autoimmune adverse effects, including kidney disease, have been reported. Only a few cases of hemolytic uremic syndrome-thrombotic microangiopathy associated interferon-alpha hav...

Full description

Bibliographic Details

Published in:	International journal of nephrology and renovascular disease Vol. 5; no. default; pp. 97 - 100
Main Authors:	Olea, Teresa, Díaz-Mancebo, Raquel, Picazo, Maria-Luz, Martínez-Ara, Jorge, Robles, Angel, Selgas, Rafael
Format:	Journal Article
Language:	English
Published:	New Zealand Dove Medical Press Limited 01-01-2012 Taylor & Francis Ltd Dove Medical Press
Subjects:	Blood clot Case Report Dosage and administration Drug therapy Interferon Physiological aspects Thrombosis Spain interferon-beta multiple sclerosis thrombotic microangiopathy hemolytic uremic syndrome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!